200 related articles for article (PubMed ID: 23809459)
1. Effect of lifetime alcohol consumption on the histological severity of non-alcoholic fatty liver disease.
Kwon HK; Greenson JK; Conjeevaram HS
Liver Int; 2014 Jan; 34(1):129-35. PubMed ID: 23809459
[TBL] [Abstract][Full Text] [Related]
2. Low to moderate lifetime alcohol consumption is associated with less advanced stages of fibrosis in non-alcoholic fatty liver disease.
Hagström H; Nasr P; Ekstedt M; Kechagias S; Önnerhag K; Nilsson E; Rorsman F; Sheikhi R; Marschall HU; Hultcrantz R; Stål P
Scand J Gastroenterol; 2017 Feb; 52(2):159-165. PubMed ID: 27650916
[TBL] [Abstract][Full Text] [Related]
3. Modest alcohol consumption is associated with decreased prevalence of steatohepatitis in patients with non-alcoholic fatty liver disease (NAFLD).
Dunn W; Sanyal AJ; Brunt EM; Unalp-Arida A; Donohue M; McCullough AJ; Schwimmer JB
J Hepatol; 2012 Aug; 57(2):384-91. PubMed ID: 22521357
[TBL] [Abstract][Full Text] [Related]
4. Type and Pattern of Alcohol Consumption is Associated With Liver Fibrosis in Patients With Non-alcoholic Fatty Liver Disease.
Mitchell T; Jeffrey GP; de Boer B; MacQuillan G; Garas G; Ching H; Hamdorf J; Adams LA
Am J Gastroenterol; 2018 Oct; 113(10):1484-1493. PubMed ID: 29899440
[TBL] [Abstract][Full Text] [Related]
5. Alcohol consumption is associated with progression of hepatic fibrosis in non-alcoholic fatty liver disease.
Ekstedt M; Franzén LE; Holmqvist M; Bendtsen P; Mathiesen UL; Bodemar G; Kechagias S
Scand J Gastroenterol; 2009; 44(3):366-74. PubMed ID: 19016382
[TBL] [Abstract][Full Text] [Related]
6. Non-alcoholic steatohepatitis (NASH) in patients with polycystic ovarian syndrome (PCOS).
Hossain N; Stepanova M; Afendy A; Nader F; Younossi Y; Rafiq N; Goodman Z; Younossi ZM
Scand J Gastroenterol; 2011 Apr; 46(4):479-84. PubMed ID: 21114431
[TBL] [Abstract][Full Text] [Related]
7. Non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in Albanian overweight children.
Kodhelaj K; Resuli B; Petrela E; Malaj V; Jaze H
Minerva Pediatr; 2014 Feb; 66(1):23-30. PubMed ID: 24608579
[TBL] [Abstract][Full Text] [Related]
8. [Clinical and histological features of non-alcoholic fatty liver disease].
Shi JP; Xun YH; Hu CB; Zhang L; Liu H; Lou GQ; Fan JG
Zhonghua Gan Zang Bing Za Zhi; 2009 Nov; 17(11):812-6. PubMed ID: 19958638
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of non-alcoholic fatty liver disease and advanced fibrosis in Hong Kong Chinese: a population study using proton-magnetic resonance spectroscopy and transient elastography.
Wong VW; Chu WC; Wong GL; Chan RS; Chim AM; Ong A; Yeung DK; Yiu KK; Chu SH; Woo J; Chan FK; Chan HL
Gut; 2012 Mar; 61(3):409-15. PubMed ID: 21846782
[TBL] [Abstract][Full Text] [Related]
10. Surgical treatment of non-alcoholic steatohepatitis and non-alcoholic fatty liver disease.
Weiner RA
Dig Dis; 2010; 28(1):274-9. PubMed ID: 20460923
[TBL] [Abstract][Full Text] [Related]
11. Silent non-alcoholic fatty liver disease-a clinical-histological study.
Sorrentino P; Tarantino G; Conca P; Perrella A; Terracciano ML; Vecchione R; Gargiulo G; Gennarelli N; Lobello R
J Hepatol; 2004 Nov; 41(5):751-7. PubMed ID: 15519647
[TBL] [Abstract][Full Text] [Related]
12. Effects of light-to-moderate alcohol consumption on steatosis and steatohepatitis in severely obese patients.
Cotrim HP; Freitas LA; Alves E; Almeida A; May DS; Caldwell S
Eur J Gastroenterol Hepatol; 2009 Sep; 21(9):969-72. PubMed ID: 19194305
[TBL] [Abstract][Full Text] [Related]
13. ADH1B∗2 Is Associated With Reduced Severity of Nonalcoholic Fatty Liver Disease in Adults, Independent of Alcohol Consumption.
Vilar-Gomez E; Sookoian S; Pirola CJ; Liang T; Gawrieh S; Cummings O; Liu W; Chalasani NP
Gastroenterology; 2020 Sep; 159(3):929-943. PubMed ID: 32454036
[TBL] [Abstract][Full Text] [Related]
14. Final results of a long-term, clinical follow-up in fatty liver patients.
Dam-Larsen S; Becker U; Franzmann MB; Larsen K; Christoffersen P; Bendtsen F
Scand J Gastroenterol; 2009; 44(10):1236-43. PubMed ID: 19670076
[TBL] [Abstract][Full Text] [Related]
15. Metabolic and histological features of non-alcoholic fatty liver disease patients with different serum alanine aminotransferase levels.
Wong VW; Wong GL; Tsang SW; Hui AY; Chan AW; Choi PC; Chim AM; Chu S; Chan FK; Sung JJ; Chan HL
Aliment Pharmacol Ther; 2009 Feb; 29(4):387-96. PubMed ID: 19035982
[TBL] [Abstract][Full Text] [Related]
16. Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes.
Fracanzani AL; Valenti L; Bugianesi E; Andreoletti M; Colli A; Vanni E; Bertelli C; Fatta E; Bignamini D; Marchesini G; Fargion S
Hepatology; 2008 Sep; 48(3):792-8. PubMed ID: 18752331
[TBL] [Abstract][Full Text] [Related]
17. Not only type 2 diabetes but also prediabetes is associated with portal inflammation and fibrosis in patients with non-alcoholic fatty liver disease.
Yilmaz Y; Senates E; Yesil A; Ergelen R; Colak Y
J Diabetes Complications; 2014; 28(3):328-31. PubMed ID: 24602757
[TBL] [Abstract][Full Text] [Related]
18. Depression, anxiety, and nonalcoholic steatohepatitis.
Elwing JE; Lustman PJ; Wang HL; Clouse RE
Psychosom Med; 2006; 68(4):563-9. PubMed ID: 16868265
[TBL] [Abstract][Full Text] [Related]
19. Risk factors associated with nonalcoholic fatty liver disease and its relationship with the hepatic histological changes.
Rodríguez-Hernández H; Gonzalez JL; Márquez-Ramirez MD; Flores-Hernandez M; Rodríguez-Morán M; Guerrero-Romero F
Eur J Gastroenterol Hepatol; 2008 May; 20(5):399-403. PubMed ID: 18403941
[TBL] [Abstract][Full Text] [Related]
20. Validation of the non-alcoholic fatty liver disease activity score.
Hjelkrem M; Stauch C; Shaw J; Harrison SA
Aliment Pharmacol Ther; 2011 Jul; 34(2):214-8. PubMed ID: 21585409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]